Effect of decoction on CD14 expression in lipopolysaccharide signal transduction
pathway of alcohol-induced liver disease in rats
Effect of decoction on CD14 expression in lipopolysaccharide signal transduction
pathway of alcohol-induced liver disease in rats
Rui ZHU MD 1, Lin SHEN MD 1, Jianguo LIU MD 1, Weili ZHANG MM 1, Ling YANG MD 2,
1.Department of Traditional
Chinese Medicine, Union Hospital, Tongji Medical College, Huazhong
University of Science and Technology, Wuhan 430022, China; 2.Department of Gastroenterology,
Union Hospital, Tongji Medical College, Huazhong University of Science
and Technology, Wuhan 430022, China;
Abstract：This paper aims to investigate the effects of Zhihuang (枳黄) decoction on CD14 expression in the lipopolysaccharide signal transduction pathway of alcohol-induced liver disease in rats. Seventy-five Wistar rats were randomly divided into three groups. Ethanol (56%, weight/volumn) was intragastrically administrated to 50 rats (14mL/kg body weight per day) for 10 days to establish a model of alcohol-induced liver disease, and 25 of these 50 rats were treated with Zhihuang decoction simultaneously. Liver injury was evaluated by biochemical examination. The plasma content of endotoxin was assayed by biochemistry. The expression of CD14 mRNA and protein in rat liver was measured by reverse transcriptional polymerase chain reaction and immunohistochemistry, respectively. Zhihuang decoction pretreatment significantly protected against acute alcohol-induced liver injury, which was evidenced by the decrease of elevated serum alanine aminotransferase and aspartate aminotransferase. In addition, the level of plasma endotoxin and up-regulation of CD14 was also suppressed by Zhihuang decoction in alcohol-intoxicated rats. Zhihuang decoction can significantly reduce CD14 expression in the lipopolysaccharide signal transduction pathway, which is one of the most important mechanisms of Zhihuang decoction to treat hepatic injury induced by alcohol in rats.
. Effect of decoction on CD14 expression in lipopolysaccharide signal transduction
pathway of alcohol-induced liver disease in rats[J]. Front. Med., 2009, 3(3): 363-367.
Rui ZHU MD , Lin SHEN MD , Jianguo LIU MD , Weili ZHANG MM , Ling YANG MD , . Effect of decoction on CD14 expression in lipopolysaccharide signal transduction
pathway of alcohol-induced liver disease in rats. Front. Med., 2009, 3(3): 363-367.
Zhao J, Chen H, Li Y. Protective effect of bicyclol on acute alcohol-inducedliver injury in mice. Eur J Pharmacol, 2008, 586(1): 322―331 doi: 10.1016/j.ejphar.2008.02.059
Moriarty K J, Platt H, Crompton S, Darling W, Blakemore M, Hutchinson S, Proctor D, Brown M, Burtun B, Lipscomb G, Padmakumar K. Collaborative care for alcoholrelated liver disease. Clin Med, 2007, 7(2): 125―128
Zhu R, Yang L, Shen L, Ye J, Liu J G, Hu S J. ANG II-AT1 receptor pathway is involved in the anti-fibrotic effectof β-elemene. J Huazhong Univ SciTechnol [Med Sci], 2009, 29(2): 177―181
Stern M, Carter E A, Walker W A. Food proteins and gut mucosal barrier. IV. Effects ofacute and chronic ethanol administration on handling and uptake ofbovine serum albumin by rat small intestine. Dig Dis Sci, 1986, 31(11): 1242―1248 doi: 10.1007/BF01296527
Parlesak A, Schäfer C, Schütz T, Bode JC, Bode C. Increased intestinal permeability tomacromolecules and endotoxemia in patients with chronic alcohol abusein different stages of alcohol-induced liver disease. J Hepatol, 2000, 32(5): 742―747 doi: 10.1016/S0168-8278(00)80242-1
Fukui H, Brauner B, Bode J C, Bode C. Plasma endotoxinconcentrations in patients with alcoholic and non-alcoholic liverdisease: reevaluation with an improved chromogenic assay. J Hepatol, 1991, 12(2): 162―169 doi: 10.1016/0168-8278(91)90933-3
Bode C, Kugler V, Bode J C. Endotoxemia in patients with alcoholic and non-alcoholiccirrhosis and in subjects with no evidence of chronic liver diseasefollowing acute alcohol excess. J Hepatol, 1987, 4(11): 8―14 doi: 10.1016/S0168-8278(87)80003-X
Nanji A A, Khettry U, Sadrzadeh S M, Yamanaka T. Severityof liver injury in experimental alcoholic liver disease: correlationwith plasma endotoxin, prostaglandin E2, leukotriene B4 and thromboxaneB2. Am J Pathol, 1993, 142(11): 367―373
Mathison J C, Ulevitch R J. The clearance, tissue distribution,and cellular localization of intravenously injected lipopolysaccharidein rabbits. J Immunol, 1979, 123(5): 2133―2143
Zlydaszyk J C, Moon R J. Fate of 51Cr-labeled lipopolysaccharide in tissue culture cellsand livers of normal mice. Infect Immun, 1976, 14(1): 100―105
Bigatello L M, Broitman S A, Fattori L, Di Paoli M, Pontello M, Bevilacqua G, Nespoli A. Endotoxemia,encephalopathy, and mortality in cirrhotic patients. Am J Gastroenterol, 1987, 82(1): 11―15
Lin R S, Lee F Y, Lee S D, Tsai Y T, Lin H C, Lu R H, Hsu W C, Huang C C, Wang S S, Lo K J. Endotoxemia in patients with chronicliver diseases: relationship to severity of liver diseases, presenceof esophageal varices and hyperdynamic circulaton. J Hepatol, 1995, 22(2): 165―172 doi: 10.1016/0168-8278(95)80424-2
Nolan J P. The role of endotoxin in liver injury. Gastroenterology, 1975, 69(6): 1346―1356
Nolan J P, Camara D S. Intestinal endotoxins asco-factorsin liver injury. Immunol Invest, 1989, 18(1―4): 325―337 doi: 10.3109/08820138909112246
Urbaschek R, McCuskey R S, Rudi V, Becker K P, Stickel F, Urbaschek B, Seitz H K. Endotoxin,endotoxin-neutral- lizing-capacity, sCD14, sICAM-1, and cytokinesin patients with various degrees of alcoholic liver disease. Alcohol Clin Exp Res, 2001, 25(2): 261―268 doi: 10.1111/j.1530-0277.2001.tb02207.x
Kitano H, Fukui H, Okamoto Y, Kikuchi E, Matsumoto M, Kikukawa M, Morimura M, Tsujita S, Nagamoto I, Nakatani T, Takaya A, Tsujii T. Role of albumin and high-density lipoprotein as endotoxin-bindingproteins in rats with acute and chronic alcohol loading. Alcohol Clin Exp Res, 1996, 20(1): 73―76 doi: 10.1111/j.1530-0277.1996.tb01735.x
Beutler B. TNF,immunity and inflammatory disease: lessons of the past decade. J Inv Med, 1995, 43(3): 227―235
Jacob C O. Tumor necrosis factor-α in autoimmunity: pretty girl or oldwitch? Immunol Today, 1992, 13(1): 122―125 doi: 10.1016/0167-5699(92)90107-I
Järveläinen H A, Orpana A, Perola M, Savolainen V T, Karhunen P J, Lindros K O. Promoter polymorphism of the CD14 endotoxin receptorgene as a risk factor for alcoholic liver disease. Hepatology, 2001, 33(1): 1148―1153 doi: 10.1053/jhep.2001.24236
Landmann R, Knopf H P, Link S, Sansano S, Schumann R, Zimmerli W. Human monocyte CD14 is upregulated by lipopolysaccharide. Infect Immun, 1996, 64(5): 1762―1769
Yin M, Ikejima K, Wheeler M D, Bradford B U, Seabra V, Forman D T, Sato N, Thurman R G. Estrogen is involved in earlyalcohol-induced liver injury in a rat enteral feeding model. Hepatology, 2000, 31(1): 117―123 doi: 10.1002/hep.510310119
Dai L L, Gong J P, Zuo G Q, Wu C X, Shi Y J, Li X H, Peng Y, Deng W, Li S W, Liu C A. Synthesis of endotoxin receptor CD14protein in Kupffer cells and its role in alcohol-induced liver disease. World J Gastroenterol, 2003, 9(3): 622―626
Yin M, Bradford B U, Wheeler M D, Uesugi T, Froh M, Goyert S M, Thurman R G. Reduced early alcohol-induced liver injury in CD14-deficient mice. J Immunol, 2001, 166(7): 4737―4742
